Remington-Davis Clinical Research is a clinical research site located in Columbus, Ohio, United States 43215.
Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.
Remington-Davis Clinical Research has participated in 16 clinical trials with 6 currently active.
Therapeutic areas: Migraine, Erythropoietic Protoporphyria, Erythropoietic Protoporphyria (EPP).
Sponsors: Avulux, Inc., Disc Medicine, Inc, Tanabe Pharma America, Inc..
Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Remington-Davis Clinical Research has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Remington-Davis Clinical Research has 16 clinical trials on record, with 6 currently active. Their work covers Migraine, Erythropoietic Protoporphyria, Erythropoietic Protoporphyria (EPP).
Yes — Remington-Davis Clinical Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.